Biologically active, high levels of interleukin-22 inhibit hepatic gluconeogenesis but do not affect obesity and its metabolic consequences
Crossref DOI link: https://0-doi-org.brum.beds.ac.uk/10.1186/s13578-015-0015-0
Published Online: 2015-05-30
Published Print: 2015-12
Update policy: https://0-doi-org.brum.beds.ac.uk/10.1007/springer_crossmark_policy
Park, Ogyi
Ki, Sung Hwan
Xu, Mingjiang
Wang, Hua
Feng, Dechun
Tam, Joseph
Osei-Hyiaman, Douglas
Kunos, George
Gao, Bin
License valid from 2015-05-30
Article History
Received: 24 March 2015
Accepted: 14 May 2015
First Online: 30 May 2015